Takeda Pharmaceutical Co Ltd - May 5, 2021 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
10%+ Owner
Signature
/s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Stock symbol
PHAT
Transactions as of
May 5, 2021
Transactions value $
-$250,803
Form type
4
Date filed
5/7/2021, 07:22 AM
Next filing
May 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$244K -6.94K -0.66% $35.14 1.04M May 5, 2021 Direct F1, F2
transaction PHAT Common Stock Sale -$7.07K -202 -0.02% $35.01 1.04M May 6, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
F2 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.91. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
F3 Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.03. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.